Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 697 Official Publication of Indian Association of Medical Microbiologists 
  Search
 
 ~ Next article
 ~ Previous article 
 ~ Table of Contents
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (174 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
 ~  References

 Article Access Statistics
    Viewed2492    
    Printed70    
    Emailed5    
    PDF Downloaded455    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
CORRESPONDENCE
Year : 2008  |  Volume : 26  |  Issue : 4  |  Page : 398
 

Imipenem resistant metallo β lactamse producing Pseudomonas aeruginosa


Department of Microbiology, Dr. L.H. Hiranandani Hospital, Powai, Mumbai - 400 076, Maharashtra, India

Date of Submission09-Jan-2008
Date of Acceptance01-Feb-2008

Correspondence Address:
A Varaiya
Department of Microbiology, Dr. L.H. Hiranandani Hospital, Powai, Mumbai - 400 076, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0255-0857.43565

Rights and Permissions



How to cite this article:
Chacko B, Varaiya A, Dedhia B. Imipenem resistant metallo β lactamse producing Pseudomonas aeruginosa. Indian J Med Microbiol 2008;26:398

How to cite this URL:
Chacko B, Varaiya A, Dedhia B. Imipenem resistant metallo β lactamse producing Pseudomonas aeruginosa. Indian J Med Microbiol [serial online] 2008 [cited 2019 Aug 25];26:398. Available from: http://www.ijmm.org/text.asp?2008/26/4/398/43565


Dear Editor,

Pseudomonas aeruginosa, an important nosocomial pathogen is difficult to treat because of high antimicrobial resistance. [1] The common form of resistance is mediated by lack of drug penetration and / or carbapenem hydrolyzing β-lactamases. [2] Detection of metallo β lactamase (MBL)-producing P. aeruginosa is crucial for the optimal treatment of patients. The present study was undertaken to study Imipenem resistant P. aeruginosa for MBL production.

Seventy six Pseudomonas aeruginosa isolates were obtained from various types of specimens (38 respiratory secretions, 10 body fluids, 10 pus swabs, 8 catheter tips, 5 catheterized urine samples and 5 - blood culture) over a one year period from October 2006 to September 2007. Isolates were identified by standard laboratory techniques and antibiotic sensitivity was performed on Mueller Hinton Agar plates by Kirby Bauer disc diffusion method using commercially available discs (Hi Media) according to CLSI guidelines. [3] Disc approximation test was used to detect MBL production - the zone size difference between imipenem alone and imipenem+EDTA being ≥ 7 mm. P. aeruginosa ATCC 27853 was used as a negative control.

In this study 11 out of 76 (14.47%) strains were resistant to imipenem. Of these 11 strains, 8 (10.53%) were found positive for MBL production. Strains producing metallo beta lactamase were 100% sensitive to colistin, 81% to piperacillin/ tazobactam and 54% to gatifloxacin. Thus, MBL production was observed in multiresistant P. aeruginosa which were imipenem resistant.

EDTA impregnated imipenem discs can be easily used and are inexpensive for primary screening for multi drug resistant P. aeruginosa isolates. Sensitivity to Colistin represents the best treatment option for metallo betalactamase producing P. aeruginosa .

 
 ~ References Top

1.Poirel L, Nordmann P. Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support. Curr Pharma Biotech 2002;3:117-27.  Back to cited text no. 1    
2.Hemalatha V, Sekar U, Vijaylakshmi K. Detection of Metallo betalactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2005;122:148-52.  Back to cited text no. 2    
3.Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; 9 th ed. Vol.26 2006. p. M2-A9.  Back to cited text no. 3    



This article has been cited by
1 Management of antibiotic resistance in the intensive care unit setting
Nicola Petrosillo, Alessandro Capone, Stefano Di Bella, Fabrizio Taglietti
Expert Review of Anti-infective Therapy. 2010; 8(3): 289
[VIEW] | [DOI]



 

Top
Print this article  Email this article
Previous article Next article

    

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04